Skip to Main content Skip to Navigation
Journal articles

A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis

Abstract : Schizophrenia is an illness characterized by positive symptoms, negative symptoms, and cognitive impairments. Cognitive impairments occur before the onset of psychosis and could reflect glutamatergic dysregulation. Thus, identifying associations between genetic variations in genes coding for glutamatergic receptors and cognitive impairment in schizophrenia may help in understanding the basis of these deficits and in identifying potential drug targets. In a discovery cohort of 144 first-episode of psychosis patients (FEP), we genotyped 58 candidate Single Nucleotide Polymorphisms (SNPs) located in NMDA and metabotropic glutamatergic receptors. These SNPs were selected according to the results from the Psychiatric Genomic Consortium and were tested for association with intellectual quotient (IQ) as assessed with the Wechsler Intelligence Scales. For replication, we used the ICAAR cohort including 121 ultra-high-risk patients (UHR) with the same cognitive assessment. A polymorphism located in GRM7, rs1396409, was significantly associated with performance IQ in the discovery cohort of FEP. This association was replicated in the UHR cohort. This polymorphism is also associated with total IQ and verbal IQ in the merged dataset, with a predominant effect on the arithmetic subtest. The rs1396409 polymorphism is significantly associated with cognitive impairment during the onset of psychosis. This genetic association highlights the possible impact of glutamatergic genes in cognitive deficits in the early phases of psychosis and enforces the interest for new therapeutic interventions targeting the glutamatergic pathway.
Complete list of metadatas

Cited literature [60 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02892228
Contributor : Clara Martinez Rico <>
Submitted on : Tuesday, July 7, 2020 - 2:07:57 PM
Last modification on : Monday, September 21, 2020 - 10:54:02 AM
Long-term archiving on: : Friday, November 27, 2020 - 1:29:52 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2021-01-02

Please log in to resquest access to the document

Identifiers

Collections

Citation

Boris Chaumette, Sarojini Sengupta, Martin Lepage, Ashok Malla, Srividya Iyer, et al.. A polymorphism in the glutamate metabotropic receptor 7 is associated with cognitive deficits in the early phases of psychosis. Schizophrenia Research, Elsevier, 2020, Online ahead of print. ⟨10.1016/j.schres.2020.06.019⟩. ⟨inserm-02892228⟩

Share

Metrics

Record views

30